Crinetics Director Sells 5,000 Shares: Key Takeaways
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
72 articles
Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Lenz Therapeutics Stock Plummeted This Week: Why It Happened
This week brought a sharp decline in lenz therapeutics stock plummeted as concerns about revenue growth and financing...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Celcuity Stock Popped Today: Key Drivers Behind the Jump
Celcuity stock popped today after the company released its 2025 results, showing a tighter quarterly loss despite no ...
Erasca CMO's Direct Stake Goes to Zero: Investor Implications
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Stock Market Today, March: Wave Life Dives After Data Disappoints
A biotech name drops sharply after mixed obesity data, sending Wave Life Sciences and the broader market into a brief...
Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Cytosorbents (CTSO) 2025 Earnings Outlook for Investors
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Lucid Diagnostics (LUCD) Earnings: Outlook and Analysis
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
Stoke Therapeutics CMO Stock Sale Sparks Investor Debate
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
Tarsus Pharma Stock Insider Activity Spurs 20% Rally
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
Related Topics
#Investing (55)
#Stock Analysis (16)
#Earnings Analysis (16)
#Stock Market News (11)
#Earnings (8)
#Stock Market (7)
#Portfolio Management (7)
#Insider Trading (7)
#Portfolio Strategy (6)
#risk-management (5)
#Hedge Funds (5)
#Investing Strategies (3)
#Investing Strategy (3)
#CRISPR (3)
#Viking Therapeutics (3)